Together Pharma Ltd (TLV:TGTR)
Israel · Delayed Price · Currency is ILS · Price in ILA 207.60
+2.90 (1.42%)
Oct 1, 2026, 2:24 PM IDT
Together Pharma Market Cap
Together Pharma has a market cap or net worth of 36.01 million as of October 2, 2026. Its market cap has decreased by -42.41% in one year.
Market Cap
36.01M
Enterprise Value
96.23M
Revenue
99.94M
Ranking
n/a
PE Ratio
n/a
Stock Price
207.60
ChartMarket Cap Chart
Since September 24, 2012, Together Pharma's market cap has decreased from 40.78M to 36.01M, a decrease of -11.68%. That is a compound annual growth rate of -0.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 36.01M | -38.01% |
| Dec 31, 2025 | 58.09M | 7.36% |
| Dec 31, 2024 | 54.11M | 58.74% |
| Dec 31, 2023 | 34.09M | 82.59% |
| Dec 29, 2022 | 18.67M | -72.51% |
| Dec 30, 2021 | 67.91M | -50.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Danel (Adir Yeoshua) | 2.55B |
| Amal Holdings A.D. | 2.23B |
| Rafa Laboratories | 1.75B |
| BrainsWay | 1.56B |
| Almeda Ventures Limited Partnership | 48.35M |
| BioLineRx | 38.83M |
| Clal Biotechnology Industries | 37.96M |
| Allmed Solutions | 32.80M |